Valeant Extends Tender Offer for Allergan

Aug. 15 (Bloomberg) -- Valeant Pharmaceuticals said it extended its offer to purchase Allergan until the end of the year, after an initial deadline for its tender offer was scheduled to expire today. Pimm Fox reports on "Taking Stock." (Source: Bloomberg)